相关实验视频

Updated: Sep 13, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

在癌症免疫治疗中,脂质纳米粒子介导的mRNA输送

Gyati Shilakari Asthana¹, Saptarshee Bhattacharjee², Jitendra Kumar²

¹Gokaraju Rangaraju College of Pharmacy, Hyderabad, Telangana, India.

Advances in immunology

|July 30, 2025

概括

脂质纳米颗粒 (LNPs) 为癌症免疫疗法提供信使RNA (mRNA). 这项技术保护mRNA,向癌细胞,增强免疫反应,提供了一个有前途的新治疗策略.

科学领域:

生物技术是生物技术.
免疫学免疫学免疫学
纳米医学是一种纳米医学.

背景情况:

使者RNA (mRNA) 疗法为癌症治疗提供了一种新的方法.
脂质纳米粒子 (LNP) 对于有效安全地传递mRNA至关重要.
癌症免疫疗法旨在利用患者的免疫系统来对抗癌症.

研究的目的:

探索LNP在癌症免疫疗法的mRNA输送中的作用.
讨论LNP在癌症治疗中的特性,机制和优化.
审查LNP介导的mRNA疗法的当前和未来应用.

主要方法:

审查LNP的组成,结构和功能修改.
对mRNA保护和细胞传递的LNP机制的分析.
检查LNP表面功能化和克服瘤微环境障碍的研究.

主要成果:

临床核蛋白保护mRNA免受降解,并促进其进入细胞.
优化的LNP提高了准特异性,降低了毒性,并提高了治疗疗效.
临床前和临床研究表明,LNP介导的mRNA癌症疫苗和疗法取得了成功.

结论:

临床核蛋白是基于mRNA的癌症免疫疗法的转变性技术.
在LNP设计的进一步进步为个性化癌症治疗提供了潜力.
解决分娩的挑战,非目标效应和免疫反应是未来发展的关键.

关键词:

癌症免疫疗法癌症免疫疗法临床应用临床应用脂质纳米颗粒的使用方法临床前证据临床前证据目标化目标化目标化目标化 m mRNA mRNA 的时间.

更多相关视频

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...